To investigate the biological functions of MYH9 in glioblastoma, we first discovered through a glioma chip (HBraG160Su01) that the expression of MYH9 increases with the pathological grade (Fig. S4A, S4B, Supporting Information). This evidence concerns the gene MYH9 and central nervous system cancer.